Start Learning Free

Before You Begin

Question #46508

Difficulty: 8/10 | 🟢 Free

The Question

A patient with Adenosine Deaminase (ADA) deficiency receives an infusion of genetically engineered lymphocytes containing functional ADA cDNA. Despite successfully mounting a primary immune response to a novel pathogen shortly after treatment, the patient fails to mount an effective anamnestic (secondary) response to the same pathogen a few years later without further treatment. Which of the following best explains the fundamental biological limitation of this specific therapeutic approach?

Options

  • A.

    The retroviral vector used for transfection induces RNA interference, preventing the rapid translation of antibodies during the secondary response.

  • B.

    The genetically corrected lymphocytes are not immortal; thus, the pool of memory cells required for sustained clonal proliferation eventually depletes.

  • C.

    The introduced ADA cDNA fails to integrate into the host genome, preventing the initial maturation of T and B lymphocytes in the bone marrow.

  • D.

    The accumulation of deoxyadenosine in the engineered cells selectively destroys memory B cells while sparing short-lived effector T cells.

Check Your Answer

Correct Answer

Step-by-Step Solution

Explanation

How the Examiner Thinks

Comparative_Analysis

Sharpen your ability to evaluate multiple scenarios and distinguish between competing potential answers.

Concepts Behind This Question

Adenosine Deaminase|T-lymphocyte differentiation|Hematopoietic Stem Cells

Why This Question Is Tricky

Common Mistakes

Conceptual Pivot: Students often memorize that gene therapy 'treats' ADA deficiency but fail to integrate the NCERT detail regarding lymphocyte mortality with the immunological concept of memory cells.

The trap lies in assuming that a successful primary response guarantees a secondary response, overlooking that somatic gene therapy does not confer immortality to the engineered cells, thereby preventing long-term immunological memory unless stem cells are targeted.

Quick Facts About This Question

Question Information

SubjectBiology
ChapterHuman Health and Disease - Class 12
ConceptPrimary vs Secondary Immune Response
Difficulty8
Cognitive Load5
Target Solve Time120 sec
AccessFree